Evidence map›Paper›PMID 41636797›Full record

ArticleEuropean biophysics journal : EBJ2026

The role of heterogeneity of intersubunit interfaces in the outer membrane leaflet in maintaining GABAA receptor activity.

Alexey Rossokhin

Abstract read
PubMed Publisher
In one paragraph

Article in European biophysics journal : EBJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alexey RossokhinResearch Center of Neurology, Brain Science Institute, by-str. Obukha 5, Moscow, 105064, Russia. alrossokhin@yahoo.com.ORCID http://orcid.org/0000-0001-7024-7461

Funding

Russian Science Foundation 25-23-000303
6 · The paper itself

Abstract

GABA type A receptors (GABAAR) mediate fast inhibition processes in the CNS. We proposed that β2 Arg269 (19′) residue maintains the activated state of GABAAR by wedging its bulky side chain into β(+)/α(–) transmembrane interfaces in the outer membrane leaflet. To explore this hypothesis, we used the cryo-EM structure (6X3Z) of agonist-bound α1β2γ2 GABAAR and molecular dynamics. We found that the Arg19′ side chain tends to adopt a horizontal conformation at β(+)/α(–) interfaces, in which it forms strong contacts with both interface sides, thereby wedging the interfaces. We found that due to the presence of the γ subunit, two β(+)/α(−) interfaces are not identical in terms of the Arg19′ side chain dynamics. At other interfaces, the Arg19′ side chain adopts a vertical conformation in which it forms strong contacts only with residues from the principal subunit. We identified residues 15′, 20′, and 29′ of the principal subunits responsible for this difference in the Arg19′ side chain dynamics. We constructed models of mutant GABAAR in which the Arg19′ side chain dynamics in the two above interface groups are opposite to those of wild-type receptor. In this work, we proposed a new molecular mechanism for maintaining GABAAR in the activation state.

Indexed as

Cell MembraneReceptors, GABA-AAnimalsMolecular Dynamics SimulationMutationProtein ConformationProtein SubunitsProtein SubunitsReceptors, GABA-AArg19′Arg269GABAARGABA type A receptorsIntersubunit interfacesModelingMolecular dynamics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.